A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50
Public ClinicalTrials.gov record NCT04192630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Document the Safety and Effectiveness of a New Cohesive OVD When Compared to a Control OVD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.
Study identification
- NCT ID
- NCT04192630
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 390 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 25, 2019
- Primary completion
- Jan 30, 2022
- Completion
- Jan 30, 2022
- Last update posted
- May 27, 2024
2019 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 10
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 017 | Chandler | Arizona | 85224 | — |
| Bausch Site 001 | Phoenix | Arizona | 85032 | — |
| Bausch Site 008 | Fayetteville | Arkansas | 72704 | — |
| Bausch Site 010 | Burlingame | California | 94010 | — |
| Bausch Site 007 | Garden Grove | California | 92843 | — |
| Bausch Site 011 | Newport Beach | California | 92662 | — |
| Bausch Site 012 | Northridge | California | 91325 | — |
| Bausch Site 013 | Rancho Cordova | California | 95670 | — |
| Bausch Site 004 | Torrance | California | 90505 | — |
| Bausch Site 019 | Bloomington | Minnesota | 55420 | — |
| Bausch Site 020 | Kansas City | Missouri | 64154 | — |
| Bausch Site 002 | St Louis | Missouri | 63131 | — |
| Bausch Site 015 | Washington | Missouri | 63090 | — |
| Bausch Site 005 | New York | New York | 10013 | — |
| Bausch Site 021 | Mason | Ohio | 45040 | — |
| Bausch Site 003 | Reading | Pennsylvania | 96002 | — |
| Bausch Site 014 | Goodlettsville | Tennessee | 37073 | — |
| Bausch 018 | Nashville | Tennessee | 37215 | — |
| Bausch Site 009 | Cedar Park | Texas | 78613 | — |
| Bausch Site 006 | Houston | Texas | 77008 | — |
| Bausch 022 | San Antonio | Texas | 78215 | — |
| Bausch Site 016 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04192630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2024 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04192630 live on ClinicalTrials.gov.